Devonian Health Group Announces trading on the OTCQB® Market under symbol DVHGF
PRESS RELEASE For immediate release Devonian Health Group Announces trading on the OTCQB® Market under symbol DVHGF. QUEBEC, March 10, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical...
DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS. QUEBEC, March 7, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical...
Devonian Health Group Announces voting results of the Annual General and Special Meeting and welcome new board members
PRESS RELEASE For immediate release Devonian Health Group Announces voting results of the Annual General and Special Meeting and welcome new board members. QUEBEC, – March 1st , 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a...
DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER AND GRANT OF STOCK OPTIONS
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER AND GRANT OF STOCK OPTIONS. QUEBEC, January 31st, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD),...
Devonian Announces Adoption of Shareholder Rights Plan and Modification to a Private Placement
PRESS RELEASE For immediate release Devonian Announces Adoption of Shareholder Rights Plan and Modification to a Private Placement. Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, January 27, 2022...
Devonian Health Group Announces Application for OTCQB listing
PRESS RELEASE For immediate release Devonian Health Group Announces Application for OTCQB listing. QUEBEC, January 11, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation,...
Devonian Health Group Announces Publication of article on potential use of Thykamine™ in the treatment of Covid-19 in the International Journal of Noncommunicable Diseases
PRESS RELEASE For immediate release Devonian Health Group Announces Publication of article on potential use of Thykamine™ in the treatment of Covid-19 in the International Journal of Noncommunicable Diseases. QUEBEC, December 8, 2021 – Devonian Health Group...
Devonian Announces Closing of an oversubscribed private placement of $10,000,000
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF SUBORDINATE VOTING SHARES IN SETTLEMENT OF A DEBT OWED TO A CONSULTANT AND THE GRANT OF STOCK OPTIONS. Not for distribution to United States newswire services or for dissemination in the...
DEVONIAN ANNOUNCES THE ISSUANCE OF SUBORDINATE VOTING SHARES IN SETTLEMENT OF A DEBT OWED TO A CONSULTANT AND THE GRANT OF STOCK OPTIONS
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF SUBORDINATE VOTING SHARES IN SETTLEMENT OF A DEBT OWED TO A CONSULTANT AND THE GRANT OF STOCK OPTIONS. QUÉBEC, November 24, 2021 – Devonian Health Group Inc. (“Devonian” or the...
Devonian Health Group Announces Closing of the First Tranche of a Private Placement of $2,292,199.50
PRESS RELEASE For immediate release Devonian Health Group Announces Closing of the First Tranche of a Private Placement of $2,292,199.50. Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, November...